Michael Grundei

Experience

  • Represented numerous publicly traded companies in connection with their Securities Exchange Act compliance and other securities matters, including Hudson Technologies, Inc. (Nasdaq), Misonix, Inc. (Nasdaq), CAS Medical Systems, Inc. (Nasdaq), Biodel Inc. (Nasdaq), TRC Companies, Inc. (NYSE) and ATMI, Inc. (Nasdaq)
  • Represented CAS Medical Systems, Inc. (Nasdaq) in all aspects of its sale, via cash out merger, to a subsidiary of Edwards Lifesciences Corporation (NYSE)

  • Represented Hudson Technologies, Inc. (Nasdaq) in connection with the $220 million acquisition of Airgas Refrigerants, Inc. and related term and revolving debt financings
  • Represented Hudson Technologies, Inc. (Nasdaq) in connection with a $50 million secondary public offering of common stock underwritten by William Blair & Company and Craig-Hallum Capital Group
  • Represented Biodel Inc. (Nasdaq) in connection with a $35 million secondary public offering of common stock underwritten by William Blair & Company and Ladenburg Thalmann
  • Represented The Hour Publishing Company in connection with the sale of its media assets to Hearst
  • Represented CAS Medical Systems, Inc. (Nasdaq) in connection with the sale of its neonatal intensive care disposables product line to Trinity Medical Devices Inc.
  • Represented R Tape Corp. in connection with its sale to Nekoosa Coated Products, a portfolio company of Wingate Partners
  • Represented UIL Holdings Corporation (NYSE) in connection with a $500 million public offering of common stock underwritten by Morgan Stanley, JP Morgan and BofA Merrill Lynch
  • Represented Latex Foam International Holdings, Inc. in connection with the corporate aspects of its financial restructuring and emergence from Chapter 11 bankruptcy